Warby Parker Analyst Ratings
Warby Parker (WRBY) Gets a Hold From Loop Capital Markets
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Warby Parker (WRBY) and Adaptive Biotechnologies (ADPT)
Warby Parker Analyst Ratings
Telsey Advisory Remains a Buy on Warby Parker (WRBY)
Morgan Stanley Lifts Price Target on Warby Parker to $14 From $13, Keeps Equalweight Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)
JMP Securities Remains a Hold on Warby Parker (WRBY)
Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL) and Warby Parker (WRBY)
Warby Parker Analyst Ratings
Warby Parker (WRBY) Gets a Buy From Telsey Advisory
Warby Parker Maintains Buy Rating: Strong Growth and Solid Fundamentals Despite EBITDA Miss
Warby Parker (WRBY) Receives a Hold From Stifel Nicolaus
Piper Sandler Keeps Their Buy Rating on Warby Parker (WRBY)
Buy Rating Reaffirmed for Warby Parker Amid Positive Revenue Trajectory and Strategic Growth Initiatives
JMP Securities Remains a Hold on Warby Parker (WRBY)
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Warby Parker (WRBY)
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Owens & Minor (OMI) and Warby Parker (WRBY)
Warby Parker Analyst Ratings
Warby Parker Analyst Ratings